Genomic impact of transient low-dose decitabine treatment on primary AML cells

Title
Genomic impact of transient low-dose decitabine treatment on primary AML cells
Authors
Keywords
-
Journal
BLOOD
Volume 121, Issue 9, Pages 1633-1643
Publisher
American Society of Hematology
Online
2013-01-09
DOI
10.1182/blood-2012-09-459313

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now